A new drug responsible for microvesicular steatosis: ticlopidine
Remy, A.J.; Heran, B.; Galindo, G.; Tapie, C.; Khemissa, F.; Larrey, D.
Gastroenterologie Clinique et Biologique 23(1): 151-152
1999
ISSN/ISBN: 0399-8320 PMID: 10219621 Document Number: 508105
Document emailed within 1 workday
Related Documents
Ionescu, D.L. 2002: Microvesicular steatosis Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 107(2): 268-272Sevenet, F.; Sevestre, H.; Masmoudi, K.; Capron, J.P. 1988: Massive microvesicular steatosis and Wilson's disease Gastroenterologie Clinique et Biologique 12(10): 764-765
Fréneaux, E.; Pessayre, D. 1993: Drug-induced steatosis, phospholipidosis and pseudo-alcoholic liver disorders Gastroenterologie Clinique et Biologique 17(5 Part 2): H36-H43
Sergiacomo, L.; Ciancaglini, R.; Orlando, D.; Delle Monache, G.; Pesa, O. 1986: Treatment of alcoholic hepatic steatosis with metadoxine. Preliminary results on the evaluation of the effects of the drug by an ultrasonographic study La Clinica Terapeutica 119(2): 133-141
Lons, T.; Chousterman, M. 1991: Simvastatin: a new drug responsible for acute pancreatitis? Gastroenterologie Clinique et Biologique 15(1): 93-94
Sundlof, S.F. 1993: Availability and use of existing scientific information for responsible drug prescribing Journal of the American Veterinary Medical Association 202(10): 1696-9;discussion 1713-7
Nolla Panades, R.; Nolla Salas, M.; Alvarez Lerma, F.; Torres Rodríguez, J.M. 1980: Treatment of microvesicular hydatidosis with mebendazole Revista Clinica Espanola 156(4): 295-303
Saibara, T.; Himeno, H.; Ueda, H.; Onishi, S.; Yamamoto, Y.; Enzan, H.; Hara, H.; Takehara, Y.; Utsumi, K. 1994: Acute hepatic failure with swollen mitochondria and microvesicular fatty degeneration of hepatocytes triggered by free radical initiator Laboratory Investigation; A Journal of Technical Methods and Pathology 70(4): 517-524
Tohgi, H. 2006: Ticlopidine Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 7): 570-575
Nechifor, M. 1992: Ticlopidine and its use in therapy Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 96(1-2): 39-40
Bertrand, J.L. 1972: Physiopathology of ethylic steatosis Lyon Medical 227(2): 123-138
Thaler, H. 1975: Relation of steatosis to cirrhosis Clinics in Gastroenterology 4(2): 273-280
González Sánchez, J.A.; Martín Molinero, R.; Domínguez Sayans, J.; Placer Galán, C.; Rivera García, T. 1990: Focal steatosis of the liver Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 77(5): 373-375
Bedossa, P.; Lemaigre, G.; Martin, E. 1989: Alcoholic pancreatic steatosis Gastroenterologie Clinique et Biologique 13(6-7): 642-643
Asselah, T.; Ripault, M.-P.; Marcellin, P. 2003: What does chronic hepatitis C steatosis mean? Gastroenterologie Clinique et Biologique 27(12): 1073-1075
Boustière, C.; Gauthier, A. 1985: Non-alcoholic hepatic steatosis Presse Medicale 14(20): 1147-1150
Filippini, L. 1972: Therapy of hepatic steatosis Minerva Medica 63(31): 1815-1817
Strauss, E.; Ugriumov, N.; Gayotto, L.C. 1979: Acute steatosis in pregnancy Revista Paulista de Medicina 93(5-6): 120-123
Hagymási, K.; Fehér, J.án. 2005: Non-alcoholic steatosis/steatohepatitis Orvosi Hetilap 146(28): 1494-1495
Marmont, A.M.; Lotti, G.; Nati, S.; Martinengo, M.; Morgano, A. 1985: Agranulocytosis caused by ticlopidine Recenti Progressi in Medicina 76(5): 245-248